VivaTech International, Inc.   Report issue

For profit Phase 2
Founded: Pittsburgh PA United States (2015)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2015
NCT02844751
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

platelet-rich plasma (3 trials)

stromed (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Hip (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2